BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 7981510)

  • 1. Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide.
    Hamm B; Staks T; Taupitz M; Maibauer R; Speidel A; Huppertz A; Frenzel T; Lawaczeck R; Wolf KJ; Lange L
    J Magn Reson Imaging; 1994; 4(5):659-68. PubMed ID: 7981510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver and spleen enhancement after intravenous injection of carboxydextran magnetite: effect of dose, delay of imaging, and field strength in an ex vivo model.
    Caramella D; Jin XN; Mascalchi M; Agen C; Petruzzi P; Kresse M; Bianucci D; Ceretti E; Semmler W; Bartolozzi C
    MAGMA; 1996; 4(3-4):225-30. PubMed ID: 9220411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR imaging of the liver and spleen: a comparison of the effects on signal intensity of two superparamagnetic iron oxide agents.
    Chen F; Ward J; Robinson PJ
    Magn Reson Imaging; 1999 May; 17(4):549-56. PubMed ID: 10231181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RES-specific imaging of the liver and spleen with iron oxide particles designed for blood pool MR-angiography.
    Bremer C; Allkemper T; Baermig J; Reimer P
    J Magn Reson Imaging; 1999 Sep; 10(3):461-7. PubMed ID: 10508309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
    Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
    Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of superparamagnetic iron-oxide MR contrast agents in the rat.
    Majumdar S; Zoghbi SS; Gore JC
    Invest Radiol; 1990 Jul; 25(7):771-7. PubMed ID: 2391194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superparamagnetic iron oxide hepatic MR imaging: efficacy and safety using conventional and fast spin-echo pulse sequences.
    Schwartz LH; Seltzer SE; Tempany CM; Silverman SG; Piwnica-Worms DR; Adams DF; Herman L; Herman LA; Hooshmand R
    J Magn Reson Imaging; 1995; 5(5):566-70. PubMed ID: 8574043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual contrast enhancement of both T1- and T2-weighted sequences using ultrasmall superparamagnetic iron oxide.
    Small WC; Nelson RC; Bernardino ME
    Magn Reson Imaging; 1993; 11(5):645-54. PubMed ID: 8345779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of fast and ultrafast T2-weighted MR imaging sequences in hepatic enhancement with ferumoxides: comparison with conventional spin-echo sequence.
    Abe Y; Yamashita Y; Namimoto T; Tang Y; Takahashi M
    Radiat Med; 2000; 18(2):97-105. PubMed ID: 10888042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in hepatic uptake and distribution of organ-specific superparamagnetic MRI contrast media: clinical findings and classification according to pathogenesis.
    Macarini L; Marini S; Murrone M; Ettorre GC
    Radiol Med; 2004; 108(1-2):92-106. PubMed ID: 15269693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles.
    Grangier C; Tourniaire J; Mentha G; Schiau R; Howarth N; Chachuat A; Grossholz M; Terrier F
    J Comput Assist Tomogr; 1994; 18(6):888-96. PubMed ID: 7962795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-to-echo optimization for spin echo magnetic resonance imaging of liver metastasis using superparamagnetic iron oxide particles.
    Alger JR; Harreld JH; Chen S; Mintorovitch J; Lu DS
    J Magn Reson Imaging; 2001 Nov; 14(5):586-94. PubMed ID: 11747011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of focal liver lesions with superparamagnetic iron oxide: value of STIR and SE imaging.
    Halavaara JT; Lamminen AE; Bondestam S; Standertskjöld-Nordenstam CG; Hamberg LM
    J Comput Assist Tomogr; 1994; 18(6):897-904. PubMed ID: 7962796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence.
    Chambon C; Clement O; Le Blanche A; Schouman-Claeys E; Frija G
    Magn Reson Imaging; 1993; 11(4):509-19. PubMed ID: 8316064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical results with Resovist: a phase 2 clinical trial.
    Reimer P; Rummeny EJ; Daldrup HE; Balzer T; Tombach B; Berns T; Peters PE
    Radiology; 1995 May; 195(2):489-96. PubMed ID: 7724772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superparamagnetic iron oxide (SPIO) MRI contrast agent for bone marrow imaging: differentiating bone metastasis and osteomyelitis.
    Fukuda Y; Ando K; Ishikura R; Kotoura N; Tsuda N; Kato N; Yoshiya S; Nakao N
    Magn Reson Med Sci; 2006 Dec; 5(4):191-6. PubMed ID: 17332709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions.
    Winter TC; Freeny PC; Nghiem HV; Mack LA; Patten RM; Thomas CR; Elliott S
    AJR Am J Roentgenol; 1993 Dec; 161(6):1191-8. PubMed ID: 8249724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
    Tanabe M; Ito K; Shimizu A; Fujita T; Onoda H; Yamatogi S; Washida Y; Matsunaga N
    Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
    Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
    Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superparamagnetic iron oxide particles (SH U 555 A): evaluation of efficacy in three doses for hepatic MR imaging.
    Shamsi K; Balzer T; Saini S; Ros PR; Nelson RC; Carter EC; Tollerfield S; Niendorf HP
    Radiology; 1998 Feb; 206(2):365-71. PubMed ID: 9457187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.